The research team, led by Di Zhao, Kai Dong, and Chengji Zhao, constructed what are known as vitrimers: crosslinked polymers that contain dynamic covalent bonds capable of exchanging with one another when heated. Unlike conventional thermosets, whose networks are permanently frozen, vitrimers can rearrange their topology, allowing them to be self-healed, welded, reprocessed, and chemically degraded on demand. Dynamic bonds such as disulfides, Schiff bases, and siloxane linkages have been incorporated into epoxy systems before, but a persistent problem has haunted the field: making a network more dynamic usually makes it weaker. High crosslinking density delivers stiffness and strength but immobilizes the polymer chains, producing brittleness and sluggish bond exchange. Lowering the crosslink density restores mobility but sacrifices mechanical robustness. Most attempts to escape this dilemma have relied on rubber toughening, thermoplastic blending, or inorganic nanofillers—additives that complicate the formulation, disrupt network homogeneity, and can themselves impair recyclability.

The team’s strategy was different. Rather than adding anything, they engineered the intrinsic free volume of the network—the fraction of space within the material that is not occupied by polymer chains. Free volume is often treated as an incidental byproduct of molecular packing, but the researchers proposed treating its size and spatial distribution as a tunable structural parameter in its own right. To test the idea, they designed two renewable-resource-derived epoxy monomers: a bifunctional monomer called VAN-EP, built from vanillin, and a trifunctional monomer called PCA-EP, derived from protocatechualdehyde. Both carry rigid conjugated Schiff base scaffolds formed by amine-aldehyde condensation, and both were cured with 1,3-bis(3-aminopropyl) tetramethyldisiloxane, a flexible siloxane-containing amine, producing rigid-flexible networks held together by two types of dynamic bonds: imine and siloxane.

Molecular dynamics simulations revealed how profoundly the monomer functionality shaped the internal architecture. The bifunctional VAN-BAS system exhibited a fractional free volume of 38.3 percent, roughly 29 percent higher than the 29.7 percent of the trifunctional PCA-BAS network. The denser trifunctional system packs its chains more tightly because its excess crosslinking points impose localized confinement. The consequences rippled through every property measured. The diffusion coefficient of VAN-BAS, a measure of translational molecular mobility, was 12 percent higher than that of PCA-BAS, and its van der Waals interaction energy was substantially more negative, indicating that moderate free volume actually allows chains to arrange more efficiently and stabilize intermolecular interactions rather than simply loosening the structure.

Mechanically, the two materials diverged in exactly the way the free-volume framework predicts. PCA-BAS, with a crosslink density of 3880 moles per cubic meter—41 percent higher than VAN-BAS—showed greater stiffness, with a storage modulus of 5115 megapascals and a glass transition temperature of 127 degrees Celsius. But its restricted segmental mobility made it brittle. VAN-BAS, by contrast, achieved a tensile strength of 94.3 megapascals, a flexural strength of 168.7 megapascals, and an impact strength of 39.1 kilojoules per square meter, surpassing PCA-BAS by 26, 31, and 46 percent respectively. Fracture surface analysis told the story visually: VAN-BAS broke with a rough, fish-scale morphology studded with fine wrinkles, the signature of extensive plastic deformation and energy dissipation, while PCA-BAS displayed the smooth, flat river-pattern characteristic of brittle fracture. The nanoscale voids in VAN-BAS act simultaneously as shock absorbers, accommodating local chain deformation and relieving stress concentrations, and as molecular lubricants that enable efficient energy dissipation during crack propagation.

Thermal performance remained competitive despite the differences in network density. The thermal decomposition temperatures at five percent weight loss were 294 degrees Celsius for VAN-BAS and 307 degrees for PCA-BAS, a modest 13-degree gap given the substantial difference in crosslinking. The researchers attribute this resilience to the strong intermolecular interactions of the conjugated imine bonds, which suppress thermal molecular motion. In PCA-BAS, the restricted chain mobility even promotes formation of a stable carbonaceous char layer at high temperature, which acts as a thermal barrier and raises the char yield.

The most striking results concerned dynamics. Counterintuitively, PCA-BAS, despite containing a higher total concentration of dynamic covalent bonds, relaxed stress more slowly than VAN-BAS. When heated from 140 to 200 degrees Celsius, the stress relaxation time of VAN-BAS dropped from 426 to 45 seconds, while PCA-BAS required 786 to 65 seconds over the same range. The activation energy for topological rearrangement was 59.6 kilojoules per mole for VAN-BAS versus 70.5 for PCA-BAS, and the extrapolated topological freezing temperature was nearly 19 degrees lower for the freer network. The lesson is that bond concentration alone does not govern network reorganization kinetics; the dense crosslinking of PCA-BAS imposes steric constraints that raise the energy barrier for bond exchange and outweigh the benefit of having more dynamic bonds to exchange. In self-healing tests, a scratch on VAN-BAS closed almost completely within 60 minutes at 200 degrees Celsius, while PCA-BAS managed only a 77 percent width reduction in the same time.

Reprocessing confirmed the practical payoff. Pulverized VAN-BAS hot-pressed at 200 degrees Celsius and 15 megapascals for 30 minutes reformed into smooth, coherent specimens with retained chemical structure and stable thermomechanical properties, though tensile strength fell to 64 percent of the original after one cycle and 57 percent after two—better retention than PCA-BAS, which dropped to 61 and then 50 percent, but a reminder that repeated thermal remolding still accumulates damage. The team suggests that optimized reprocessing conditions, additional dynamic mechanisms, or nanofillers could improve retention in future work.

The real-world test came with carbon fiber-reinforced composites, the application where epoxy’s recycling problem is most acute. Large composite panels measuring 300 by 300 millimeters were fabricated by compression molding, and the CF/VAN-BAS laminates achieved a tensile strength of 605 megapascals, a flexural strength of 628 megapascals, and an interlaminar shear strength of 68 megapascals—exceeding the CF/PCA-BAS equivalents by 11, 21, and 24 percent. The dynamic network enabled adhesive-free welding of overlapping laminates with a lap shear strength of 31.3 megapascals, competitive with or superior to recent advanced welding methods, and the welded joints could sustain a 3-kilogram load, roughly a thousand times their own weight. Laminates were also thermoformed into a stable W-shaped three-dimensional component and then flattened back without delamination, with the reconfigured parts bearing compressive peak loads of 748 newtons.

Perhaps most consequentially for sustainability, the free-volume-tailored matrix degraded gently under solvent. Immersion in dimethylformamide at 120 degrees Celsius caused the network to swell and fragment within about four hours, releasing the carbon fibers intact. The recovered fibers showed smooth, defect-free surfaces under electron microscopy and retained 96 percent of their original tensile strength, with surface chemistry and graphitization degree essentially unchanged according to X-ray photoelectron and Raman spectroscopy. At least 90 percent of the solvent was recoverable by rotary evaporation, and the process required no catalyst, though the authors note that full life-cycle and techno-economic assessment remains future work. Taken together, the study establishes fractional free volume as a genuine design principle for covalently adaptive polymers—one that decouples strength from toughness and dynamics from density, and points toward wind blades, aerospace panels, and structural adhesives that can be welded, reshaped, and unmade rather than landfilled.

Subject of Research: Free-volume engineering of bio-based epoxy vitrimers for recyclable carbon fiber composites

Article Title: High‐Performance Bio‐Based Epoxy Vitrimers and Composites: Synergizing Robustness and Reprocessability via Fractional Free Volume Regulation

Article References: Dong, K., Zhao, D., & Zhao, C. (2026). High‐Performance Bio‐Based Epoxy Vitrimers and Composites: Synergizing Robustness and Reprocessability via Fractional Free Volume Regulation. Advanced Science, Article e77917. https://doi.org/10.1002/advs.77917

Image Credits: AI Generated

DOI: 10.1002/advs.77917

Keywords: epoxy vitrimers, bio-based polymers, free volume, carbon fiber composites, self-healing, recyclability, dynamic covalent bonds, Schiff base, siloxane, vanillin, stress relaxation, sustainable materials

The scale of the screening was ambitious. The researchers measured 975 sweetener–bacterium pairs, growing each bacterial strain in modified Gifu anaerobic medium under strictly anaerobic conditions while exposing it to 50 micromolar concentrations of each sweetener—a level the team estimated to be within the range relevant to the human colon. Growth was tracked hourly for 24 hours, quantified as the area under the growth curve, and any apparent interaction had to pass stringent criteria: statistical significance after correction for multiple testing, a change in growth of at least 20 percent, and confirmation in an independent experiment across five different concentrations. After this rigorous validation, 30 genuine interactions emerged between 26 sweeteners and 5 bacterial strains, none of which had been reported before. Three-quarters of the tested sweeteners individually affected the growth of at least one strain.

Some bacteria proved especially sensitive. Clostridium symbiosum and Lacrimispora saccharolytica were hit by the largest number of compounds, while the sweetener component isosteviol—a stevia-derived molecule widely used in commercial formulations—emerged as the most potent single agent, inhibiting three bacterial species while paradoxically promoting the growth of Lactobacillus gasseri. But the most striking findings came when the researchers moved beyond individual compounds. Because sweeteners are rarely consumed in isolation—they appear alongside caffeine in soft drinks, vanillin in processed foods and even baby formula, and are co-formulated into pharmaceutical tablets to mask bitterness—the team screened 156 sweetener–xenobiotic combinations against all 25 bacteria, yielding 3,900 potential interactions, plus another 300 combinations involving common tablet drugs such as ibuprofen, acetaminophen, and cetirizine.

Using the Bliss model of independence, a classic pharmacological framework in which two compounds are considered synergistic if their combined effect exceeds the product of their individual effects and antagonistic if it falls short, the team identified 102 significant interactions involving nine bacterial species—68 antagonistic and 34 synergistic. Isosteviol was again central, showing combinatory effects with three of the four co-consumed compounds across five bacterial species. The strongest synergy by far was between isosteviol and duloxetine, which together inhibited Roseburia intestinalis, a butyrate-producing bacterium repeatedly linked to glucose homeostasis and protection against intestinal inflammation, and Parabacteroides merdae, a prevalent commensal associated with a healthy microbiota. On the antagonistic side, vanillin buffered the effect of saccharin against Bifidobacterium adolescentis—two compounds that frequently co-occur in processed foods.

To translate single-species effects into community-level consequences, the researchers assembled a synthetic gut community from all 25 strains and passaged it serially in the presence of the solvent control, isosteviol, duloxetine, or the combination. All compound treatments reduced species diversity, but the isosteviol–duloxetine combination was the most disruptive, significantly depleting R. intestinalis, P. merdae, Segatella copri, Bacteroides uniformis, and Phocaeicola vulgatus. Intriguingly, the picture did not simply mirror the monoculture results. R. intestinalis showed synergy in isolation but not in community, while P. merdae showed the reverse—a pattern the authors describe as emergent, meaning that ecological interactions among community members generated effects that could not be predicted from single-species data. Of the 25 strains, 24 grew worse under the combination in monoculture, yet 7 actually benefited in the community setting, underscoring how metabolic cross-feeding can reshape drug and sweetener responses.

What is the molecular mechanism behind this synergy? Proteomic analysis of R. intestinalis and P. merdae after four hours of exposure revealed that the combination produced protein abundance changes that deviated from what would be expected from purely additive single-compound effects. Eleven proteins in R. intestinalis and 29 in P. merdae responded specifically to co-exposure, with no overlap between the two species. In R. intestinalis, many changes clustered in vitamin B5 biosynthesis and fatty acid metabolism, but supplementing cultures with pantothenate, coenzyme A, and 18 other metabolic additives failed to rescue growth, ruling out this pathway as the primary target. In P. merdae, the response was dominated by cell envelope proteins: twelve upregulated proteins were transporters, efflux pump subunits, or envelope components, while the saccharide uptake system subunits SusC and SusD were downregulated—a clear signature of altered small-molecule transport across the membrane.

A genome-wide transposon mutant screen in P. merdae, using a barcoded library covering roughly 3,000 non-essential genes, reinforced this conclusion. Mutants losing the strongest fitness under co-exposure mapped to genes encoding membrane proteins, including a CorA-family putative magnesium transporter, a FadL-family hydrophobic compound transporter, a domain of the outer membrane assembly factor BamD, and a c-di-AMP phosphodiesterase ortholog implicated in membrane homeostasis in the oral pathogen Porphyromonas gingivalis. The CorA transporter stood out because it showed both strong negative fitness and increased protein abundance under duloxetine exposure—yet adding magnesium to the medium did not rescue growth, suggesting the protein performs an unknown homeostatic role rather than simply importing the ion. Bioaccumulation assays added another layer: R. intestinalis accumulated isosteviol only when duloxetine was present, while P. merdae accumulated it even without the drug, consistent with transport changes driving the synergy.

The metabolic consequences were substantial. Untargeted liquid chromatography–mass spectrometry showed that co-exposure reshaped the secreted metabolome of all three tested species, with 16 of 19 significantly altered peaks annotated as di- and tripeptides—microbial products previously linked to blood pressure regulation, Listeria infection, and intestinal inflammation. Targeted quantification of 46 metabolites revealed that in R. intestinalis, co-exposure raised glutamine secretion by roughly 50 percent (about 65 micromolar) and cut butyric acid by more than 25 percent (about 0.6 millimolar), while isovaleric acid—a metabolite correlated with depression in fecal studies—also increased. In P. merdae, asparagine concentrations shifted by more than 200 micromolar. Because butyrate fuels colonocytes, supports insulin sensitivity, and helps maintain anti-inflammatory immune tone, while glutamine can be either protective or harmful depending on context, these shifts carry real implications for host physiology.

The final experiments connected microbial chemistry back to human cells. When HeLa cells were incubated with supernatants from the 25-member community, supernatants from combination-treated communities were significantly more cytotoxic than controls—even controls where the compounds were added to supernatant only after harvesting, proving the toxicity stemmed from altered bacterial metabolism rather than the compounds themselves. In Caco-2 intestinal epithelial cells, the combination-treated supernatant suppressed secretion of the inflammatory cytokines IL-6 and IL-8 by more than 75 percent while leaving IP-10 unaffected. Because IL-6 and IL-8 coordinate neutrophil recruitment and gut defense, the authors caution that such dampening could reflect either anti-inflammatory effects or an impaired capacity to fight pathogens. The team links the cytokine changes to reduced short-chain fatty acids in the community supernatant, and shows that butyrate plus propionate can itself stimulate IL-8 secretion.

The authors are candid about limitations: the screens used a single concentration of 50 micromolar in a single growth medium, the synthetic community contains only 25 taxa, and real-world exposures are far more variable across individuals. Yet prior work suggests roughly 60 percent of monoculture drug effects are preserved in communities, making these findings a credible starting point. What the study makes unmistakably clear is that sweetener safety cannot be evaluated in isolation. Given that duloxetine alone accounted for more than 18 million prescriptions in the United States in a single year, and that sweeteners, caffeine, and vanillin saturate the modern food supply, the sweetener–xenobiotic–microbiome axis may represent an overlooked dimension of public health—one in which the bacteria in our intestines act as silent arbiters of what we eat, what we medicate with, and how our bodies respond.

Subject of Research: Interactions between low-calorie sweeteners, co-consumed xenobiotics, and human gut bacteria in vitro

Article Title: Common xenobiotics modulate gut microbial responses to low‑calorie sweeteners in vitro

Article References: Common xenobiotics modulate gut microbial responses to low‑calorie sweeteners in vitro. (n.d.). https://doi.org/10.1038/s44320-026-00225-6

Image Credits: AI Generated

DOI: 10.1038/s44320-026-00225-6

Keywords: low-calorie sweeteners, gut microbiota, xenobiotics, duloxetine, isosteviol, Roseburia intestinalis, Parabacteroides merdae, bliss synergy, metabolomics, proteomics, cytokines, microbiome